Schiff Hardin advised the underwriter on the deal.Unicycive Therapeutics (NASDAQ:UNCY) has priced its IPO of 5M units at $5.00/unit, for expected gross proceeds are $25M. Each…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Martina Bellini
…
This content is for Standard 1 Year members only. LoginJoin Now